Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction

Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction

Background: Heart rate recovery (HRR) is a marker of vagal tone, which is a powerful predictor of mortality in patients with cardiovascular disease. Sacubitril/valsartan (S/V) is a treatment for heart failure with reduced ejection fraction (HFrEF), which impressively impacts cardiovascular outcome....

Full description

Bibliographic Details
Main Authors: Francesco Giallauria, Giuseppe Vitale, Mario Pacileo, Anna Di Lorenzo, Alessandro Oliviero, Francesco Passaro, Roberta Calce, Alessandro Parlato, Crescenzo Testa, Giuseppe D’Ambrosio, Giuseppe Romano, Francesco Clemenza, Silvia Sarullo, Elio Venturini, Marco Gentile, Cinzia Nugara, Gabriella Iannuzzo, Antonello D’Andrea, Carlo Vigorito, Filippo M. Sarullo
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Journal of Clinical Medicine
Subjects:
sacubitril/valsartan
heart failure
heart rate recovery
peak oxygen consumption
autonomic function
cardiopulmonary exercise stress testing
Online Access:https://www.mdpi.com/2077-0383/9/6/1897

Internet

https://www.mdpi.com/2077-0383/9/6/1897

Similar Items